The NUCL, FLUO, MEDI, and INOR divisions are once again sponsoring a symposium highlighting the latest developments in Radiopharmaceutical Chemistry. This edition of the symposium will be held at the Spring ACS National Meeting in New Orleans, March 18-22, 2018. A special emphasis of this symposium will be to highlight Alan Davison’s many contributions to the development of metal-based radiopharmaceuticals. The Symposium will feature both invited and contributed talks on topics including:
- The production of radionuclides of radiopharmaceutical interest,
- Radiometal-based radiopharmaceuticals, and
- New and exciting 18F and 11C chemistry.
As with past radiopharmaceutical chemistry symposia, we anticipate that there will be an informal mixer at the conclusion of the symposium. We look forward to your participation.
The deadline for abstract submission is October 16, 2017.
Abstracts should be submitted though the FLUO division, since they are the primary sponsor of this symposium, through the ACS meetings website: http://www.acs.org/content/acs/en/meetings.html
Symposium Co-organizers:
- Alan B. Packard, Boston Children’s Hospital/Harvard Medical School (alan.packard AT childrens.harvard.edu)
- Neil Vasdev, Massachusetts General Hospital/Harvard Medical School (vasdev.neil AT mgh.harvard.edu)
- Suzy Lapi, University of Alabama, Birmingham (lapi AT uab.edu)
- Gilles Tamagnan, Molecular Neuroimaging, Inc. (gtamagnan AT invicro.com)